CMMB
Price
$0.68
Change
-$0.02 (-2.86%)
Updated
Apr 19, 6:59 PM EST
20 days until earnings call
SYRS
Price
$4.46
Change
-$0.26 (-5.51%)
Updated
Apr 19, 2:33 PM EST
13 days until earnings call
Ad is loading...

CMMB vs SYRS ᐉ Comparison: Which is Better to Invest?

Header iconCMMB vs SYRS Comparison
Open Charts CMMB vs SYRSBanner chart's image
Chemomab Therapeutics
Price$0.68
Change-$0.02 (-2.86%)
Volume$9.31K
CapitalizationN/A
Syros Pharmaceuticals
Price$4.46
Change-$0.26 (-5.51%)
Volume$200
CapitalizationN/A
View a ticker or compare two or three
CMMB vs SYRS Comparison Chart

Loading...

CMMBDaily Signal changed days agoGain/Loss if shorted
 
Show more...
SYRSDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
CMMB vs. SYRS commentary
Apr 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CMMB is a Hold and SYRS is a Hold.

COMPARISON
Comparison
Apr 19, 2024
Stock price -- (CMMB: $0.70 vs. SYRS: $4.72)
Brand notoriety: CMMB and SYRS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CMMB: 10% vs. SYRS: 54%
Market capitalization -- CMMB: $9.79M vs. SYRS: $124.86M
CMMB [@Biotechnology] is valued at $9.79M. SYRS’s [@Biotechnology] market capitalization is $124.86M. The market cap for tickers in the [@Biotechnology] industry ranges from $553.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.51B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CMMB’s FA Score shows that 1 FA rating(s) are green whileSYRS’s FA Score has 1 green FA rating(s).

  • CMMB’s FA Score: 1 green, 4 red.
  • SYRS’s FA Score: 1 green, 4 red.
According to our system of comparison, SYRS is a better buy in the long-term than CMMB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CMMB’s TA Score shows that 4 TA indicator(s) are bullish while SYRS’s TA Score has 4 bullish TA indicator(s).

  • CMMB’s TA Score: 4 bullish, 5 bearish.
  • SYRS’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, SYRS is a better buy in the short-term than CMMB.

Price Growth

CMMB (@Biotechnology) experienced а -7.89% price change this week, while SYRS (@Biotechnology) price change was -20.27% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.81%. For the same industry, the average monthly price growth was -5.21%, and the average quarterly price growth was +1226.26%.

Reported Earning Dates

CMMB is expected to report earnings on Aug 09, 2024.

SYRS is expected to report earnings on Aug 06, 2024.

Industries' Descriptions

@Biotechnology (-6.81% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for CMMB with price predictions.
OPEN
A.I.dvisor published
a Summary for SYRS with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
SYRS($125M) has a higher market cap than CMMB($9.79M). CMMB YTD gains are higher at: 37.255 vs. SYRS (-39.410).
CMMBSYRSCMMB / SYRS
Capitalization9.79M125M8%
EBITDAN/AN/A-
Gain YTD37.255-39.410-95%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
SYRS: Fundamental Ratings
SYRS
OUTLOOK RATING
1..100
67
VALUATION
overvalued / fair valued / undervalued
1..100
66
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
40
P/E GROWTH RATING
1..100
9
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CMMBSYRS
RSI
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
76%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 23 days ago
88%
Bullish Trend 10 days ago
74%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 2 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
82%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
View a ticker or compare two or three
Ad is loading...
CMMBDaily Signal changed days agoGain/Loss if shorted
 
Show more...
SYRSDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CPOP1.760.05
+3.11%
Pop Culture Group Co Ltd
PFLT11.250.14
+1.26%
PennantPark Floating Rate Capital Ltd
ALG204.85-1.76
-0.85%
Alamo Group
SIRI3.06-0.04
-1.29%
Sirius XM Holdings
VABK24.36-0.64
-2.56%
Virginia National Bankshares Corp